| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/14/2004 | US6790608 Deteting modulator of membrane protein binding; obtain sample containing membrane protein, incubate with modulator, monitor adjustments in protein activity |
| 09/14/2004 | US6790607 Comprises overexpression of bait hybrid protein containing a dna binding domain (desensitization) or prey hybrid protein containing a dna activation domain for a reporter gene (enhanced sensitivity); uses exogenous activators |
| 09/14/2004 | US6790606 Extracellular matrix signaling molecules |
| 09/14/2004 | US6790604 Methods for identifying or diagnosing carcinoma cells with metastatic potential based on the measurement of lymphoid genes or their products in carcinoma cells |
| 09/14/2004 | US6790366 Magnetic separation apparatus and methods |
| 09/14/2004 | US6790365 Water-insoluble material |
| 09/14/2004 | US6790330 For detecting marker proteins and mrnas for diagnosis of cancer |
| 09/14/2004 | US6790264 Control of ammonia emission from ammonia laden fly ash in concrete |
| 09/14/2004 | US6790256 Gas carry-under monitoring and control system |
| 09/14/2004 | US6790179 Method of examining and diagnosing skin health |
| 09/14/2004 | US6790178 Physiological monitor and associated computation, display and communication unit |
| 09/14/2004 | US6789474 Water content sensing system for ink/water emulsion of lithographic printer |
| 09/14/2004 | US6789428 Method and apparatus for evaluating damage of metal material |
| 09/14/2004 | US6789413 Method and apparatus for measuring effects of exhaust gas recirculation deposits |
| 09/14/2004 | CA2422245A1 Methods for the treatment of cellular proliferative disorders |
| 09/14/2004 | CA2245553C Process and apparatus for contactless micro injection, sorting and harvesting using laser radiation of biological objects disposed in a planar manner |
| 09/14/2004 | CA2219629C Transgenic animal models for type ii diabetes mellitus |
| 09/14/2004 | CA2198301C Portable liquid metal filtration device for inclusion analysis |
| 09/14/2004 | CA2195538C Apparatus and continuous process for making coagulation assay device |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/12/2004 | CA2456534A1 Simultaneous determination of cell proliferation inhibition activity and toxicity |
| 09/11/2004 | CA2458962A1 Method and device for analysing the co2 content in a drilling fluid |
| 09/10/2004 | WO2004077064A1 Detection and identification of anti-infective compounds involving depression |
| 09/10/2004 | WO2004077063A2 Method involving plasma membrane localisation of oxysterol biding proteins |
| 09/10/2004 | WO2004077062A2 Method for selecting a candidate drug compound |
| 09/10/2004 | WO2004077061A1 Library of compounds labelled with radioisotope |
| 09/10/2004 | WO2004077060A2 Assay for detection of renal cell carcinoma |
| 09/10/2004 | WO2004077059A1 METHOD OF IMMUNOASSAYING TARTRATE RESISTANT ACID PHOSPHATASE 5b AND KIT TO BE USED THEREIN |
| 09/10/2004 | WO2004077058A1 Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr) |
| 09/10/2004 | WO2004077056A1 A method of diagnosis and agents useful for same |
| 09/10/2004 | WO2004077055A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/10/2004 | WO2004077054A1 Quality control of binding measurements on microarrays |
| 09/10/2004 | WO2004077052A1 Analyte test instrument having improved versatility |
| 09/10/2004 | WO2004077050A1 Test sample for non-destructive testing and test methods |
| 09/10/2004 | WO2004077049A1 Quality control method for article and oxygen detecting agent for use therein |
| 09/10/2004 | WO2004077041A1 Analytic chip for quantifying nucleic acid concentration, analytic device for quantifying nucleic acid concentration and analytic method for quantifying nucleic acid concentration |
| 09/10/2004 | WO2004077036A1 Method and apparatus for characterising multiphase fluid mixtures |
| 09/10/2004 | WO2004077034A1 Bioanalytical method based on measurement of the phosphorescence decay period |
| 09/10/2004 | WO2004077028A1 Device for measuring immunochromatography test piece |
| 09/10/2004 | WO2004077021A2 Standardized evaluation of therapeutic efficacy based on cellular biomarkers |
| 09/10/2004 | WO2004077015A2 Method for analysis of contaminants in a process fluid stream |
| 09/10/2004 | WO2004077011A2 Generic method for latex agglutination assays |
| 09/10/2004 | WO2004077010A2 Water channel assays |
| 09/10/2004 | WO2004077007A2 Detection, quantification and composition for cytochrome c released from mitochondria |
| 09/10/2004 | WO2004076944A2 Gas monitoring system and sidestream gas measurement system adapted to communicate with a mainstream gas measurement system |
| 09/10/2004 | WO2004076689A1 Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same |
| 09/10/2004 | WO2004076686A1 Method of examining cell |
| 09/10/2004 | WO2004076684A2 Compositions and methods for the detection of mammalian muscle troponin i |
| 09/10/2004 | WO2004076682A2 Targets for controlling cellular growth and for diagnostic methods |
| 09/10/2004 | WO2004076679A2 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer |
| 09/10/2004 | WO2004076678A2 Translucent solid matrix assay device for microarray analysis |
| 09/10/2004 | WO2004076677A2 Monoclonal antibody production by ebv transformation of b cells |
| 09/10/2004 | WO2004076666A1 Gasdermin family |
| 09/10/2004 | WO2004076658A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 09/10/2004 | WO2004076656A1 Stabilised composition for fluorimetric, colorimetric or chemoluminescent assays, kits containing same and production method thereof |
| 09/10/2004 | WO2004076648A2 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 09/10/2004 | WO2004076646A2 Methods and compositions for treating cervical cancer |
| 09/10/2004 | WO2004076643A2 CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076632A2 Methods of screening for trpm5 modulators |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076610A1 Apparatus and method for machining microchamber for cell culture |
| 09/10/2004 | WO2004076511A2 Photocrosslinked hydrogel surface coatings |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076482A1 Soluble factor secreted by endothelial cells in blood vessels |
| 09/10/2004 | WO2004076480A1 Tumour marker and its use |
| 09/10/2004 | WO2004076473A2 Androgen receptor interacting peptides |
| 09/10/2004 | WO2004076054A2 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| 09/10/2004 | WO2004075882A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 09/10/2004 | WO2004075865A2 Selective modulation of tlr-mediated biological activity |
| 09/10/2004 | WO2004075842A2 Mrp3 genes and uses thereof |
| 09/10/2004 | WO2004075839A2 Methods and compositions for modulating apoptosis |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075830A2 Knockout identification of target-specific sites in peptides |
| 09/10/2004 | WO2004075818A2 Stress specific molecular response in neurons |
| 09/10/2004 | WO2004075814A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 i (prostaglandin e2 ep3 i) |
| 09/10/2004 | WO2004075813A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |
| 09/10/2004 | WO2004075812A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 3b (pde3b) |
| 09/10/2004 | WO2004075724A2 Serotonin and catecholamine system segment optimization technology |
| 09/10/2004 | WO2004075723A2 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | WO2004075713A2 Multiple marker assay for detection of ovarian cancer |
| 09/10/2004 | WO2004065963A3 Improved beta-arrestin based screening assays |
| 09/10/2004 | WO2004065928A3 Light induced immobilisation |
| 09/10/2004 | WO2004065626A3 A method of sepsis prognosis |
| 09/10/2004 | WO2004063753A3 A serum marker for measuring liver fibrosis |
| 09/10/2004 | WO2004058393A3 Method for the validated construction of arrays |
| 09/10/2004 | WO2004058175A3 Novel use of liver x receptor agonists |
| 09/10/2004 | WO2004051214A3 Use of fluorine nmr for high throughput screening |
| 09/10/2004 | WO2004048947A8 Methods and appartus for molecular species detection, inspection and classification using ultraviolet fluorescence |
| 09/10/2004 | WO2004047854A3 Methods for the treatment of alzheimers disease and compositions therefore |
| 09/10/2004 | WO2004044241A3 Use of fish larvae as a screening model |
| 09/10/2004 | WO2004044204A3 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 09/10/2004 | WO2004042360A3 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| 09/10/2004 | WO2004042023A3 Stem cell libraries |
| 09/10/2004 | WO2004039841A3 Trimeric binding proteins for trimeric cytokines |
| 09/10/2004 | WO2004039829A3 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 09/10/2004 | WO2004037278A3 Delocalization molecules and use thereof |
| 09/10/2004 | WO2004036215A3 Diagnostic markers for therapeutic treatment |
| 09/10/2004 | WO2004034033A3 Methods and systems for detecting mhc class i and class ii binding peptides |
| 09/10/2004 | WO2004034018B1 Multihued labels |